Table 3: LV diastolic functional parameters
Healthy Normotensives Controlled hypertension Hypertension with systolic BP 140–159 mmHg Hypertension with systolic BP ≥ 160 mmHg
Group n 852 206 501 148
Adjusted Mean (CI) Adjusted Mean (CI) Adjusted Mean (CI) Adjusted Mean (CI) p-value
TD septal s´ (cm/s) 7.9 (7.7–8.2) 8.0 (7.7–8.3) 7.9 (7.6–8.1) 8.0 (7.7–8.3) 0.866
TD lateral s´ (cm/s) 8.9 (8.5–9.2) 8.9 (8.4–9.3) 8.8 (8.4–9.1) 8.8 (7.8–8.7)* 0.430
TD septal e’ (cm/s) 9.3 (9.0–9.6) 8.5 (8.1–8.9)* 8.3(8.0–8.6)* 8.0 (7.6–8.5)* <0.001
MV velocity E (cm/s) 68 (66–71) 70 (67–73) 68 (66–70) 70 (66–73) 0.347
MV E DT (ms) 183(177–189) 189 (181–197) 190 183–198)* 197 (188–206)* 0.003
MV A velocity (cm/s) 61 (59–63) 64 (62–67)* 66 (64–68)* 67 (65–68)* <0.001
E/A ratio () 1.19 (1.15–1.24) 1.16 (1.10–1.21) 1.10 (1.05–1.15)* 1.11 (1.05–1.17)* <0.001
LA diameter (cm) 21.2 (20.7–21.6) 21.0 (20.5–21.5) 21.7 (21.3–22.2)*† 21.9 (21.4–22.5)*† <0.001
LA volume Index (ml/m2) 22.8 (21.7–24.0 24.0 (22.5–25.4) 24.1 (22.9–25.3) 24.8 ±9 (23.1–26.4 0.017
TR max peak gradient (mmHg) 14.3(13.2–15.4) 16.4 (15.0–17.8)* 15.3 (13.5–16.7) 15.1 (13.5–16.7) 0.010
Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C Means derived from multiple linear regression analysis adjusted for age, sex, height, body mass index, heart rate, atrial fibrillation and Russian/Norwegian population. CI: Confidence interval TD: tissue doppler; MV: mitral valve; DT: deceleration time; TR: tricuspid regurgitation Pairwise comparisons with adjustment for multiple comparisons: * p<0.05 for difference towards group A † p<0.05 for difference towards group B ‡ p<0.05 for difference towards group C